Scrog CBD by Medicann Seeds
Indica genetics × Sativa genetics
Scrog CBD by Medicann Seeds is a hybrid strain developed to balance CBD benefits with desirable indica and sativa genetics. It is recognized for its consistent cannabinoid profile and appealing visual characteristics, making it a notable achievement in modern cannabis breeding.
Appearance
Scrog CBD buds are dense and well-formed, displaying a mix of green hues complemented by purple and orange pistils. A fine dusting of trichomes covers the buds, indicating high-quality genetics and careful cultivation. The strain's vibrant colors remain consistent even with moderate temperature fluctuations.
Aroma & Flavor
The aroma of Scrog CBD is a complex blend featuring floral and spicy notes from linalool and nerolidol, with underlying earthy tones. Myrcene and limonene contribute herbal and citrus nuances, respectively. Upon tasting, users experience floral and earthy flavors with hints of spice, followed by citrus accents and a subtle sweet finish, creating a smooth and balanced sensory experience.
Effects
This hybrid strain is known for producing balanced effects that combine indica calmness with sativa clarity. While specific effects are not detailed, the cannabinoid profile suggests it may offer a subtle euphoric sensation without significant psychoactivity. The presence of CBD indicates potential for calming and therapeutic outcomes.
Terpenes & Cannabinoids
Scrog CBD is characterized by terpenes such as linalool, nerolidol, myrcene, and limonene. Its cannabinoid profile is notable for a significant CBD content, typically between 8% and 12%, with a low THC range of 1.5% to 3.0%. This results in a CBD to THC ratio that favors CBD, potentially enhancing therapeutic benefits through the entourage effect.
Origins & Lineage
Developed by Medicann Seeds, Scrog CBD emerged from a period of intensive breeding focused on harnessing CBD's benefits while maintaining a balance between indica and sativa genetics. The strain is the result of meticulous cross-breeding and selection from Medicann's extensive archives, aiming for genetic stability and therapeutic efficacy.